Skip to main content
. 2018 Nov 20;9(91):36273–36288. doi: 10.18632/oncotarget.26345

Figure 5. PC3 cells (control, ERβ2 and ERβ5) plated into a 96 well plate were subjected to chemotherapy treatment with docetaxel of increasing doses from 0, 8, 16, and 32 nM in the absence and presence of the ABCG2 inhibitor YHO-13351 (200 nM).

Figure 5

MTS assay was performed after 48 hours.